234 related articles for article (PubMed ID: 29195512)
1. Blood-brain barrier hyperpermeability precedes demyelination in the cuprizone model.
Berghoff SA; Düking T; Spieth L; Winchenbach J; Stumpf SK; Gerndt N; Kusch K; Ruhwedel T; Möbius W; Saher G
Acta Neuropathol Commun; 2017 Dec; 5(1):94. PubMed ID: 29195512
[TBL] [Abstract][Full Text] [Related]
2. CXCR3 modulates glial accumulation and activation in cuprizone-induced demyelination of the central nervous system.
Krauthausen M; Saxe S; Zimmermann J; Emrich M; Heneka MT; Müller M
J Neuroinflammation; 2014 Jun; 11():109. PubMed ID: 24930935
[TBL] [Abstract][Full Text] [Related]
3. Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination.
Hibbits N; Yoshino J; Le TQ; Armstrong RC
ASN Neuro; 2012 Oct; 4(6):393-408. PubMed ID: 23025787
[TBL] [Abstract][Full Text] [Related]
4. Intracerebral transplantation of interleukin 13-producing mesenchymal stem cells limits microgliosis, oligodendrocyte loss and demyelination in the cuprizone mouse model.
Le Blon D; Guglielmetti C; Hoornaert C; Quarta A; Daans J; Dooley D; Lemmens E; Praet J; De Vocht N; Reekmans K; Santermans E; Hens N; Goossens H; Verhoye M; Van der Linden A; Berneman Z; Hendrix S; Ponsaerts P
J Neuroinflammation; 2016 Nov; 13(1):288. PubMed ID: 27829467
[TBL] [Abstract][Full Text] [Related]
5. TRPA1 deficiency is protective in cuprizone-induced demyelination-A new target against oligodendrocyte apoptosis.
Sághy É; Sipos É; Ács P; Bölcskei K; Pohóczky K; Kemény Á; Sándor Z; Szőke É; Sétáló G; Komoly S; Pintér E
Glia; 2016 Dec; 64(12):2166-2180. PubMed ID: 27568827
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Stereotactic Injections on Demyelination and Remyelination: a Study in the Cuprizone Model.
Tejedor LS; Wostradowski T; Gingele S; Skripuletz T; Gudi V; Stangel M
J Mol Neurosci; 2017 Apr; 61(4):479-488. PubMed ID: 28124770
[TBL] [Abstract][Full Text] [Related]
7. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
[TBL] [Abstract][Full Text] [Related]
8. Astrocyte-targeted production of interleukin-6 reduces astroglial and microglial activation in the cuprizone demyelination model: Implications for myelin clearance and oligodendrocyte maturation.
Petković F; Campbell IL; Gonzalez B; Castellano B
Glia; 2016 Dec; 64(12):2104-2119. PubMed ID: 27535761
[TBL] [Abstract][Full Text] [Related]
9. Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood-Brain Barrier.
Janssen K; Rickert M; Clarner T; Beyer C; Kipp M
Mol Neurobiol; 2016 Apr; 53(3):1551-1564. PubMed ID: 25663168
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases and their tissue inhibitors in cuprizone-induced demyelination and remyelination of brain white and gray matter.
Skuljec J; Gudi V; Ulrich R; Frichert K; Yildiz O; Pul R; Voss EV; Wissel K; Baumgärtner W; Stangel M
J Neuropathol Exp Neurol; 2011 Sep; 70(9):758-69. PubMed ID: 21865884
[TBL] [Abstract][Full Text] [Related]
11. Cuprizone demyelination induces a unique inflammatory response in the subventricular zone.
Hillis JM; Davies J; Mundim MV; Al-Dalahmah O; Szele FG
J Neuroinflammation; 2016 Aug; 13(1):190. PubMed ID: 27550173
[TBL] [Abstract][Full Text] [Related]
12. Activation of the astrocytic Nrf2/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model.
Draheim T; Liessem A; Scheld M; Wilms F; Weißflog M; Denecke B; Kensler TW; Zendedel A; Beyer C; Kipp M; Wruck CJ; Fragoulis A; Clarner T
Glia; 2016 Dec; 64(12):2219-2230. PubMed ID: 27641725
[TBL] [Abstract][Full Text] [Related]
13. Reduced cuprizone-induced cerebellar demyelination in mice with astrocyte-targeted production of IL-6 is associated with chronically activated, but less responsive microglia.
Petković F; Campbell IL; Gonzalez B; Castellano B
J Neuroimmunol; 2017 Sep; 310():97-102. PubMed ID: 28778453
[TBL] [Abstract][Full Text] [Related]
14. Increased blood-brain barrier hyperpermeability coincides with mast cell activation early under cuprizone administration.
Shelestak J; Singhal N; Frankle L; Tomor R; Sternbach S; McDonough J; Freeman E; Clements R
PLoS One; 2020; 15(6):e0234001. PubMed ID: 32511268
[TBL] [Abstract][Full Text] [Related]
15. CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis.
Liu L; Belkadi A; Darnall L; Hu T; Drescher C; Cotleur AC; Padovani-Claudio D; He T; Choi K; Lane TE; Miller RH; Ransohoff RM
Nat Neurosci; 2010 Mar; 13(3):319-26. PubMed ID: 20154684
[TBL] [Abstract][Full Text] [Related]
16. The crucial role of Erk2 in demyelinating inflammation in the central nervous system.
Okazaki R; Doi T; Hayakawa K; Morioka K; Imamura O; Takishima K; Hamanoue M; Sawada Y; Nagao M; Tanaka S; Ogata T
J Neuroinflammation; 2016 Sep; 13(1):235. PubMed ID: 27596241
[TBL] [Abstract][Full Text] [Related]
17. Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease.
Yamamoto S; Yamashina K; Ishikawa M; Gotoh M; Yagishita S; Iwasa K; Maruyama K; Murakami-Murofushi K; Yoshikawa K
J Neuroinflammation; 2017 Jul; 14(1):142. PubMed ID: 28732510
[TBL] [Abstract][Full Text] [Related]
18. Cuprizone treatment induces distinct demyelination, astrocytosis, and microglia cell invasion or proliferation in the mouse cerebellum.
Groebe A; Clarner T; Baumgartner W; Dang J; Beyer C; Kipp M
Cerebellum; 2009 Sep; 8(3):163-74. PubMed ID: 19259754
[TBL] [Abstract][Full Text] [Related]
19. Remyelination after cuprizone induced demyelination is accelerated in mice deficient in the polysialic acid synthesizing enzyme St8siaIV.
Koutsoudaki PN; Hildebrandt H; Gudi V; Skripuletz T; Škuljec J; Stangel M
Neuroscience; 2010 Nov; 171(1):235-44. PubMed ID: 20833231
[TBL] [Abstract][Full Text] [Related]
20. 17beta-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss.
Taylor LC; Puranam K; Gilmore W; Ting JP; Matsushima GK
Neurobiol Dis; 2010 Aug; 39(2):127-37. PubMed ID: 20347981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
